{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:30:42Z","timestamp":1791304242819,"version":"4.3.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP200100874"],"award-info":[{"award-number":["DP200100874"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP220102236"],"award-info":[{"award-number":["DP220102236"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biomaterials.2026.124000","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:41:24Z","timestamp":1768376484000},"page":"124000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adjuvant-free biopolymer particles mimicking the Chikungunya virus surface induce protective immunity"],"prefix":"10.1016","volume":"330","author":[{"given":"Nivethika","family":"Sivakumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-0757","authenticated-orcid":false,"given":"Shuxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-564X","authenticated-orcid":false,"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-8120","authenticated-orcid":false,"given":"Lucas J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-8410","authenticated-orcid":false,"given":"Suresh","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-8903","authenticated-orcid":false,"given":"Bernd H.A.","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","article-title":"An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-53. I. Clinical features","volume":"49","author":"Robinson","year":"1955","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib2","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/s41467-021-24906-y","article-title":"A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial","volume":"12","author":"Folegatti","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124000_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","article-title":"Rheumatic manifestations of chikungunya: emerging concepts and interventions","volume":"15","author":"Suhrbier","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Pt 12","key":"10.1016\/j.biomaterials.2026.124000_bib4","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1099\/0022-1317-83-12-3075","article-title":"Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site","volume":"83","author":"Khan","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124000_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00504-19","article-title":"Infectious Chikungunya Virus (CHIKV) with a complete capsid deletion: a new approach for a CHIKV vaccine","volume":"93","author":"Zhang","year":"2019","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124000_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002124","article-title":"Effective chikungunya virus-like particle vaccine produced in insect cells","volume":"7","author":"Metz","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.biomaterials.2026.124000_bib7","series-title":"C.o.E.P.a. Innovation","year":"2017"},{"key":"10.1016\/j.biomaterials.2026.124000_bib8","series-title":"W.H. Organisation","year":"2022"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41541-024-00843-x","article-title":"Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines","volume":"9","author":"Chuong","year":"2024","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2301573","article-title":"Ixchiq (VLA1553): the first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection","volume":"15","author":"Ly","year":"2024","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2024.01.033","article-title":"Live-attenuated chikungunya virus vaccine","volume":"187","author":"Ng","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124000_bib12","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001965","article-title":"Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials","volume":"105","author":"Rao","year":"2024","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","article-title":"Chikungunya fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biomaterials.2026.124000_bib14","series-title":"Healthline","year":"2024"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"9959","key":"10.1016\/j.biomaterials.2026.124000_bib16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124000_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all Chikungunya virus genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biomaterials.2026.124000_bib18","series-title":"Nordic A\/S, VIMKUNYA\u2122 (Chikungunya Vaccine, Recombinant) Package Insert","author":"Bavarian","year":"2025"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S1473-3099(22)00226-2","article-title":"Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial","volume":"22","author":"Bennett","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biomaterials.2026.124000_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial","author":"Richardson","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2026.124000_bib21","unstructured":"L.C. Tindale, J.S. Richardson, D.M. Anderson, J. Mendy, S. Muhammad, T. Loreth, S.R. Tredo, R. Ramanathan, V.A. Jenkins, L. Bedell, P. Ajiboye, Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial, Lancet."},{"key":"10.1016\/j.biomaterials.2026.124000_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms, advances, and technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial","author":"Richardson","year":"2025","journal-title":"Lancet"},{"issue":"10165","key":"10.1016\/j.biomaterials.2026.124000_bib24","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124000_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib26","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/s41467-021-24906-y","article-title":"A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial","volume":"12","author":"Folegatti","year":"2021","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124000_bib27","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1016\/j.vaccine.2023.04.064","article-title":"A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults","volume":"41","author":"Shaw","year":"2023","journal-title":"Vaccine"},{"issue":"7706","key":"10.1016\/j.biomaterials.2026.124000_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 is a receptor for multiple arthritogenic alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124000_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1085913","article-title":"Chikungunya virus entry and infectivity is primarily facilitated through cell line dependent attachment factors in mammalian and mosquito cells","volume":"11","author":"Reyes Ballista","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124000_bib30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.cell.2019.04.008","article-title":"Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to Chikungunya Virus Envelope protein","volume":"177","author":"Song","year":"2019","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.biomaterials.2026.124000_bib31","doi-asserted-by":"crossref","first-page":"27637","DOI":"10.1073\/pnas.2008051117","article-title":"Structural basis of Chikungunya virus inhibition by monoclonal antibodies","volume":"117","author":"Zhou","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124000_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00252-20","article-title":"Anti-Chikungunya virus monoclonal antibody that inhibits viral fusion and release","volume":"94","author":"Tumkosit","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124000_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib34","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/acsomega.1c05975","article-title":"Expression, purification, and refolding of Chikungunya virus full-length envelope E2 protein along with B-Cell and T-Cell epitope analyses using immuno-informatics approaches","volume":"7","author":"Shukla","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.biomaterials.2026.124000_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-4939-3618-2_27","article-title":"Production of Chikungunya virus-like particles and subunit vaccines in insect cells","volume":"1426","author":"Metz","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41541-023-00722-x","article-title":"Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need","volume":"8","author":"Cherian","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.biomaterials.2026.124000_bib38","article-title":"Vaccine development for mosquito-borne viral diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib39","article-title":"Precision-engineering of subunit vaccine particles for prevention of infectious diseases","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124000_bib40","article-title":"Ambient temperature stable, scalable COVID-19 polymer particle vaccines induce protective immunity","volume":"11","author":"Chen","year":"2022","journal-title":"Adv. Healthcare Mater."},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2026.124000_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj20031254","article-title":"Polyester synthases: natural catalysts for plastics","volume":"376","author":"Rehm","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.biomaterials.2026.124000_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2023.100018","article-title":"An overview of anti-chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies targeting diverse epitopes on the viral envelope","volume":"1","author":"Chandley","year":"2023","journal-title":"Microbe"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124000_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clim.2013.10.004","article-title":"Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model","volume":"149","author":"Goh","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1874070701812010140","article-title":"Aluminium adjuvants \u2013 a nanomaterial used as adjuvants in human vaccines for decades","volume":"12","author":"Danielsson","year":"2018","journal-title":"Open Biotechnol. J."},{"key":"10.1016\/j.biomaterials.2026.124000_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2013.10.032","article-title":"Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles","volume":"173","author":"Li","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124000_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-018-0094-0","article-title":"Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology","volume":"4","author":"Orr","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.biomaterials.2026.124000_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2016.00048","article-title":"From stock bottle to vaccine: elucidating the particle size distributions of aluminum adjuvants using dynamic light scattering","volume":"4","author":"Shardlow","year":"2017","journal-title":"Front. Chem."},{"issue":"11\u201312","key":"10.1016\/j.biomaterials.2026.124000_bib48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0264-410X(02)00556-X","article-title":"Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production","volume":"21","author":"Iyer","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124000_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0264-410X(91)90154-X","article-title":"Predicting the adsorption of proteins by aluminium-containing adjuvants","volume":"9","author":"Seeber","year":"1991","journal-title":"Vaccine"},{"issue":"7873","key":"10.1016\/j.biomaterials.2026.124000_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"7324","key":"10.1016\/j.biomaterials.2026.124000_bib51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jps.23352","article-title":"Desirable attributes of vaccines for deployment in low-resource settings","volume":"102","author":"Chen","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124000_bib53","article-title":"Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study","volume":"19","author":"Babu","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"50","key":"10.1016\/j.biomaterials.2026.124000_bib54","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1016\/j.vaccine.2018.10.033","article-title":"Defining a correlate of protection for chikungunya virus vaccines","volume":"37","author":"Milligan","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124000_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171989","article-title":"The neutralizing role of IgM during early Chikungunya virus infection","volume":"12","author":"Chua","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124000_bib56","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/eji.202049012","article-title":"Maintenance of quiescent immune memory in the bone marrow","volume":"51","author":"Chang","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib57","article-title":"Bioaccumulation of microplastics in decedent human brains assessed by pyrolysis gas chromatography-mass spectrometry","author":"Campen","year":"2024","journal-title":"Res Sq"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124000_bib58","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124000_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9060415","article-title":"Cytokines and chemokines in Chikungunya Virus infection: protection or induction of pathology","volume":"9","author":"Chirathaworn","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012075","article-title":"Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis","volume":"18","author":"Auzenbergs","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.biomaterials.2026.124000_bib61","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3389\/fmicb.2019.02881","article-title":"Recent progress in vaccine development against Chikungunya virus","volume":"10","author":"Gao","year":"2019","journal-title":"Front. Microbiol."},{"issue":"51","key":"10.1016\/j.biomaterials.2026.124000_bib62","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.vaccine.2013.09.045","article-title":"Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits","volume":"31","author":"Metz","year":"2013","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124000_bib63","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124000_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304188","article-title":"Intranasal epitope-polymer vaccine lodges resident memory T cells protecting against influenza virus","volume":"13","author":"Liu","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib65","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CVI.00687-15","article-title":"Protective T cell and antibody immune responses against hepatitis C virus achieved using a Biopolyester-Bead-Based vaccine delivery System","volume":"23","author":"Martinez-Donato","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124000_bib66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrmicro2354","article-title":"Bacterial polymers: biosynthesis, modifications and applications","volume":"8","author":"Rehm","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124000_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310517","article-title":"Heterologous DNA Prime- subunit protein boost with Chikungunya Virus E2 induces neutralizing antibodies and cellular-mediated immunity","volume":"24","author":"Coirada","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124000_bib68","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3389\/fimmu.2019.02563","article-title":"Vaccine-Induced skewing of T cell responses protects against Chikungunya Virus disease","volume":"10","author":"Broeckel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00274","article-title":"Regulatory dendritic cells: there is more than just immune activation","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1471-4906(00)01794-4","article-title":"Modulating the immune response with dendritic cells and their growth factors","volume":"22","author":"Pulendran","year":"2001","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni0901-882","article-title":"Inducible IL-2 production by dendritic cells revealed by global gene expression analysis","volume":"2","author":"Granucci","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib72","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J. Immunol."},{"issue":"6\u20137","key":"10.1016\/j.biomaterials.2026.124000_bib73","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biochi.2007.04.018","article-title":"The role of type I interferon production by dendritic cells in host defense","volume":"89","author":"Fitzgerald-Bocarsly","year":"2007","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib74","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.1102661","article-title":"The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude","volume":"188","author":"Jenkins","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124000_bib75","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/eji.200526298","article-title":"The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion","volume":"35","author":"Hopken","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124000_bib76","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2147\/DDDT.S366112","article-title":"Chikungunya vaccine candidates: current landscape and future prospects","volume":"16","author":"Schmidt","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124000_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/nano11082060","article-title":"Particulate mycobacterial vaccines induce protective immunity against tuberculosis in mice","volume":"11","author":"Chen","year":"2021","journal-title":"Nanomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124000_bib78","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1021\/acsbiomaterials.8b00579","article-title":"Design and biological assembly of polyester beads displaying pneumococcal antigens as particulate vaccine","volume":"4","author":"Gonzalez-Miro","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41541-023-00695-x","article-title":"Polymeric epitope-based vaccine induces protective immunity against group A streptococcus","volume":"8","author":"Chen","year":"2023","journal-title":"npj Vaccines"},{"issue":"10394","key":"10.1016\/j.biomaterials.2026.124000_bib80","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124000_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/d41573-024-00102-7","article-title":"FDA approves first chikungunya vaccine","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124000_bib82","series-title":"Statistical Review \u2013 VIMKUNYA (Chikungunya Vaccine, Recombinant)","author":"Administration","year":"2025"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124000_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1013226","article-title":"A biodegradable patch used as a pericardial substitute after cardiac surgery: 6- and 24-month evaluation with CT","volume":"43","author":"Duvernoy","year":"1995","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biomaterials.2026.124000_bib84","unstructured":"P.J.M. Hocking, R. H, in: G.J.L. Griffin (Ed.), Chemistry and Technology of Biodegradable Polymers, Blackie1994, pp. 48-96."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsle.2005.05.027","article-title":"In vivo monitoring of PHA granule formation using GFP-labeled PHA synthases","volume":"248","author":"Peters","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"issue":"Pt 2","key":"10.1016\/j.biomaterials.2026.124000_bib86","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/bj20030431","article-title":"Replacement of the catalytic nucleophile cysteine-296 by serine in class II polyhydroxyalkanoate synthase from pseudomonas aeruginosa-mediated synthesis of a new polyester: identification of catalytic residues","volume":"374","author":"Amara","year":"2003","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124000_bib87","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1096\/fj.201802501RR","article-title":"Innovative antigen carrier system for the development of tuberculosis vaccines","volume":"33","author":"Chen","year":"2019","journal-title":"Faseb j"},{"key":"10.1016\/j.biomaterials.2026.124000_bib88","series-title":"Compositions for Separation Methods","author":"Thompson","year":"2012"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib89","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41598-018-20205-7","article-title":"Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection","volume":"8","author":"Gonzalez-Miro","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124000_bib90","article-title":"Design of bacterial inclusion bodies as Antigen carrier systems","volume":"2","author":"Chen","year":"2018","journal-title":"Adv. Biosyst."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124000_bib91","doi-asserted-by":"crossref","first-page":"8911","DOI":"10.1021\/acsabm.0c01195","article-title":"Catalytically active bioseparation resin utilizing a covalent intermediate for tagless protein purification","volume":"3","author":"Evert","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124000_bib92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijmm.2016.10.002","article-title":"Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines","volume":"306","author":"Rubio Reyes","year":"2016","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.biomaterials.2026.124000_bib93","series-title":"Hydrocarbon and Lipid Microbiology Protocols: Bioproducts, Biofuels, Biocatalysts and Facilitating Tools","first-page":"71","article-title":"Use of bacterial polyhydroxyalkanoates in protein display technologies","author":"Hay","year":"2017"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124000_bib94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-021-00408-2","article-title":"Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites","volume":"6","author":"Evert","year":"2021","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124000_bib95","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/aem.46.6.1339-1344.1983","article-title":"Analysis of Poly-\u03b2-Hydroxybutyrate in Rhizobium japonicum bacteroids by ion-exclusion high-pressure liquid chromatography and UV detection","volume":"46","author":"Karr","year":"1983","journal-title":"Appl. Environ. Microbiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100961","article-title":"Isolation and enrichment of mouse splenic T cells for ex vivo and in vivo T cell receptor stimulation assays","volume":"2","author":"Grosjean","year":"2021","journal-title":"STAR Protoc."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124000_bib97","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/acsinfecdis.1c00434","article-title":"Intranasal delivery of antigen-coated polymer particles protects against Pseudomonas aeruginosa infection","volume":"8","author":"Gonzaga","year":"2022","journal-title":"ACS Infect. Dis."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:20:25Z","timestamp":1782188425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":97,"alternative-id":["S0142961226000244"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124000","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant-free biopolymer particles mimicking the Chikungunya virus surface induce protective immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124000"}}